Contact

Mary Ann Nichols
Vanderbilt University
medical.education@vanderbilt.edu
615-936-8510

When

Tuesday, June 9, 2015 From 2:00 PM - 4:00 PM

Add to Calendar

Where

Medical Arts Building, Room 407

June 9, 2015

"Medical Education Research and the IRB"

FACILITATOR:

Julie Damp, MD
Associate Professor of Medicine
Associate Director, Cardiovascular Medicine Fellowship Training Program

Workshop goal:

Provide attendees with a greater understanding of where Medical Education Research fits within the Institutional Review Board process.

Workshop objectives: Participants will…..

1. Be able to determine which application is best suited to their proposed project
2. Be able to distinguish quality improvement from research
3. Be able to initiate an electronic submission to the IRB

Session description:
This session will provide an overview of IRB regulations related to human subjects research. It will also include examples of different Medical Education Research projects and which route they follow during IRB review. This session will also provide a live demonstration of the IRB’s electronic study submission system (DISCOVR-E).

CME Credit:

Sponsored by Vanderbilt University School of Medicine; Office for Health Sciences Education, Educator Development Core

Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt School of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of the ACCME and Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.